PIAA promotes, protects,
educates, and connects medical
professional liability insurers who
support the quality delivery of
healthcare and practice of
Be the recognized forum and voice
of medical professional liability
For more information about the PIAA PAC and its activities, please contact Director of Government Relations, Mike Stinson
2017 Calendar of Events
2018 Calendar of Events
For Current and Archive issues of Advocacy Update click here.
View the latest installment of Inside Government Relations, a new webcast offering updates and insights on PIAA Government Relations' activities as they relate to Medical Professional Liability.
DSP participants receive a free copy of the MPL CCC and MPL SSS, as well as complimentary copies of CME Studies. Access to these publications may be requested via e-mail at firstname.lastname@example.org.
PIAA Action is dedicated to giving PIAA members and their allies an opportunity to directly reach out to federal and state lawmakers on critical medical and healthcare professional liability issues.
Sign up to become a grassroots advocate through the Quick Sign Up box located to the right.
PIAA Action may also be used to support state advocacy campaigns. For more information, please contact the PIAA Government Relations Department.
Are you using Internet Explorer?
PIAA has found compatibility issues with Internet Explorer Version 11. This will impact Meeting Registrations, Store purchases, and other protected pages on the PIAA website.
Click here for easy-to-follow information to optimize your browser. It is a one-time fix!
Wednesday, February 21, 2018
2:00-3:00 p.m. ET (1 p.m. CT, Noon MT, 11 a.m. PT)
The webinar is FREE for PIAA members. Click here to register for the webinar.
For non-members, the cost is $99. Click here to register for the webinar.
Genetic counseling and testing for patients at risk of hereditary cancer is an important consideration for any physician who may be involved in diagnosing these conditions. Among matters to consider for MPL are the relative accuracy of the tests, the requisite follow-up, the potential clinical decisions to be made based on the test results, and the related issues of costs and unnecessary treatment.
This webinar will provide an overview of the cancers known to be linked to genetic mutations and the current guides for screening at-risk patients. In addition, the speakers will present case studies— MPL lawsuits— and, based on what happened in these cases, make an estimate of the potential exposure that MPL carriers could be facing in insuring physicians who use these tests. The presentation will conclude with practical strategies that MPL carriers can use as they consider the possible risks entailed in genetic testing.
Victor Cotton MD, JD, President, Law and Medicine
Holly J. Pederson MD, Director, Medical Breast Services, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine